Prot# 104234: A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of Lapatinib in Combination with Liposomal Doxorubicin in Patients with Metastatic Breast Cancer (NU Prot# NU 05B5)

Project: Research project

Project Details

StatusFinished
Effective start/end date12/5/05 → 4/1/12

Funding

  • GlaxoSmithKline plc (104234)